Showing results (261-270 of 481) with videos related to

Sort By:
Pageof 49
Thrombosis and Haemostasis|June 4, 2008
Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 yearsLoukianos S Rallidis, Marianna Politou, Christoforos Komporozos, et al.
International Journal of Cardiology|December 2, 2014
Determinants of the direct cost of heart failure hospitalization in a public tertiary hospitalJohn Parissis, Kostas Athanasakis, Dimitrios Farmakis, et al.
European Journal of Nutrition|January 13, 2012
Adherence to Mediterranean diet and close dietetic supervision increase total dietary antioxidant intake and plasma antioxidant capacity in subjects with abdominal obesityAnastasia I Kolomvotsou, Loukianos S Rallidis, Konstantinos C Mountzouris, et al.
British Journal of Clinical Pharmacology|July 2, 2016
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patientsJolanta M Siller-Matula, Simon Specht, Jacek Kubica, et al.
Circulation. Cardiovascular Interventions|November 22, 2012
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarctionDimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Culprit plaque morphology in STEMI - an optical coherence tomography study: insights from the TOTAL-OCT substudyOlli A Kajander, Natalia Pinilla-Echeverri, Sanjit S Jolly, et al.
Journal of the American College of Cardiology|July 14, 2012
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic studyDimitrios Alexopoulos, Anastasia Galati, Ioanna Xanthopoulou, et al.
Platelets|April 15, 2021
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomesMario E Canonico, Giuseppe D Sanna, Roberta Siciliano, et al.
The American Journal of Cardiology|August 2, 2005
Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failureJohn T Parissis, Fotios Panou, Dimitrios Farmakis, et al.
Heart Rhythm|June 30, 2016
Acute effects of unilateral temporary stellate ganglion block on human atrial electrophysiological properties and atrial fibrillation inducibilityDionyssios Leftheriotis, Panayota Flevari, Charalampos Kossyvakis, et al.
Pageof 49